Bicara Therapeutics Inc. ...

14.88
-0.75 (-4.80%)
At close: Apr 25, 2025, 3:18 PM

Bicara Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
-82.39M -69.44M -58.34M -49.12M -39.89M -26.2M -16.67M -8.34M
9.01M 4.45M 1.31M 1.31M 1.31M 13K n/a n/a
-67.81M -59.47M -64.84M -58.41M -51.98M -39.55M -16.7M -8.35M
-68M -59.48M -64.84M -58.41M -51.98M -39.55M -16.7M -8.35M
18.77M 15.14M 12.97M 11.12M 9.28M 6.15M 3.56M 1.78M
63.62M 54.3M 45.37M 37.99M 30.61M 20.05M 13.11M 6.56M
n/a n/a n/a n/a n/a n/a n/a n/a
82.39M 69.44M 58.34M 49.12M 39.89M 26.2M 16.67M 8.34M
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
82.39M 69.44M 58.34M 49.12M 39.89M 26.2M 16.67M 8.34M
187K 6K 6K 5.5K 5K n/a n/a n/a
111.23M 54.41M 54.18M 54.18M 53.09M 54.41M 54.6M 54.6M
111.23M 54.41M 54.18M 54.18M 53.09M 54.41M 54.62M 54.62M
-1.05 -1.09 -1.19 -1.07 -0.95 -0.72 -0.3 -0.15
-1.05 -1.09 -1.19 -1.07 -0.95 -0.72 -0.3 -0.15
-82.33M -81.47M -70.39M -61.18M -51.96M -26.2M -16.67M -8.33M
-82.39M -81.53M -70.43M -61.21M -51.98M -26.2M -16.67M -8.34M
56K 55K 42K 30.5K 19K 5K 3K 1.5K